{"meta":{"query_hash":"9107f335891f","filters":{"venue":"The American journal of geriatric pharmacotherapy"},"cohort_total":21,"direct_labels_cover":0,"predictions_cover":21,"exported":21,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/9107f335891f","api":"https://metacan.xera.ac/api/v1/cohort?venue=%C2%98The+%C2%9CAmerican+journal+of+geriatric+pharmacotherapy"},"results":[{"id":"W1966615748","doi":"10.1016/j.amjopharm.2005.07.001","title":"Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: A case-control study","year":2005,"lang":"en","type":"article","venue":"The American journal of geriatric pharmacotherapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Donepezil; Medicine; Dementia; Disease; Health care; Geriatrics; Comorbidity; Emergency medicine; Gerontology; Internal medicine; Psychiatry","score_opus":0.014762020007161657,"score_gpt":0.3884359502343014,"score_spread":0.37367393022713974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966615748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99273306,0.0037547047,0.000011924463,0.00072862173,0.00004761889,0.0026126872,0.00008322815,0.0000068766235,0.000021253796],"genre_scores_gemma":[0.99770075,0.00090933347,0.0000921746,0.0011234888,0.00008868675,0.000034571254,0.000011154085,0.000037037025,0.0000027880776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99444455,0.0024770536,0.0013535941,0.00032575292,0.0009010515,0.00049797585],"domain_scores_gemma":[0.9969502,0.00073841563,0.0011936208,0.0002240405,0.00043221193,0.00046147438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024157432,0.00027774688,0.0009815758,0.0007701526,0.000068553214,0.000028969145,0.0001629465,0.000036027526,0.00007780008],"category_scores_gemma":[0.0001262852,0.00017494007,0.00017473238,0.0010647718,0.00011827141,0.000245155,0.000031568332,0.0009084376,9.1848995e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.065369666,0.004294683,0.82822436,0.000018712008,0.0013205423,0.0026116155,0.0051357024,0.000057950685,0.0000041322105,1.5912566e-7,0.00004630028,0.092916176],"study_design_scores_gemma":[0.09336487,0.014855101,0.8804699,0.00014146717,0.0005965251,0.000108149245,0.010161021,0.00012430467,0.0000012014212,3.5695598e-7,0.000044229648,0.00013286619],"about_ca_topic_score_codex":0.00069143384,"about_ca_topic_score_gemma":0.00047431662,"teacher_disagreement_score":0.09278331,"about_ca_system_score_codex":0.00045822863,"about_ca_system_score_gemma":0.0006750326,"threshold_uncertainty_score":0.7133849},"labels":[],"label_agreement":null},{"id":"W1968307217","doi":"10.1016/j.amjopharm.2012.03.003","title":"The Greater Sensitivity of Elderly APOE ε4 Carriers to Anticholinergic Medications is Independent of Cerebrovascular Disease Risk","year":2012,"lang":"en","type":"article","venue":"The American journal of geriatric pharmacotherapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute on Aging; National Institutes of Health; Lundbeck Canada; Neurosciences Foundation","keywords":"Medicine; Anticholinergic; Mood; Dementia; Stroke (engine); Internal medicine; Pittsburgh Sleep Quality Index; Apolipoprotein E; Anticholinergic agents; Psychiatry; Physical therapy; Disease; Cognition","score_opus":0.011245559078924557,"score_gpt":0.3212383513328226,"score_spread":0.30999279225389803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968307217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916925,0.0013963345,0.0037505915,0.0023768933,0.00020315507,0.00046067944,0.00004074014,0.0000062198646,0.00007291326],"genre_scores_gemma":[0.9951572,0.0031971873,0.00015638336,0.00084102596,0.00046713723,0.000012726846,0.0000014157519,0.000026383575,0.00014055507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685335,0.000794806,0.0006347803,0.00014866426,0.0011455013,0.00042292252],"domain_scores_gemma":[0.99719554,0.00031477225,0.0008894177,0.00035670548,0.00060458365,0.0006389799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029924174,0.00018060426,0.00048150762,0.00027202175,0.00016420653,0.000018319302,0.0002613637,0.000022592945,0.0002073613],"category_scores_gemma":[0.00007302859,0.00009991474,0.000418748,0.00080989854,0.00038951007,0.000107732696,0.000041734584,0.00036999024,0.0000071435043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036110166,0.00078534085,0.7816801,0.00005272606,0.0029266742,0.000029522116,0.0028855894,0.000032346186,0.06128545,0.000007396554,0.002464828,0.144239],"study_design_scores_gemma":[0.0043009967,0.0015636368,0.9562509,0.00006143348,0.0018336847,0.0001663682,0.0015399981,0.00020320184,0.02479578,0.00004296566,0.009047037,0.00019400915],"about_ca_topic_score_codex":0.00014033772,"about_ca_topic_score_gemma":0.0000021064168,"teacher_disagreement_score":0.17457077,"about_ca_system_score_codex":0.00006603499,"about_ca_system_score_gemma":0.00034296428,"threshold_uncertainty_score":0.40744048},"labels":[],"label_agreement":null},{"id":"W1978014016","doi":"10.1016/j.amjopharm.2012.01.003","title":"Applicability of an Adapted Medication Appropriateness Index for Detection of Drug-Related Problems in Geriatric Inpatients","year":2012,"lang":"en","type":"article","venue":"The American journal of geriatric pharmacotherapy","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Drug; Polypharmacy; Beers Criteria; Medication adherence; Index (typography); Pharmacoepidemiology; MEDLINE; Family medicine; Psychiatry; Intensive care medicine; Pharmacology; Medical prescription; Internal medicine; Computer science","score_opus":0.03779602966875733,"score_gpt":0.3602725158744262,"score_spread":0.3224764862056689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978014016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887386,0.0009236923,0.00816227,0.00021988363,0.0005023287,0.0013935696,0.000011676781,0.000013192291,0.000034788492],"genre_scores_gemma":[0.9982044,0.000565899,0.0006834222,0.00017933792,0.00026458065,0.00005240472,0.0000063490825,0.00003486278,0.000008750658],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99693316,0.00049363135,0.0014453349,0.0001830954,0.0006038925,0.00034087562],"domain_scores_gemma":[0.9956464,0.00047435035,0.002916825,0.00025231586,0.00044425766,0.00026584385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025413218,0.00021065101,0.00078507455,0.00045178118,0.000051203464,0.0000065348568,0.00027240292,0.000068100366,0.000045487963],"category_scores_gemma":[0.00008188654,0.00014405233,0.00022134442,0.0015916837,0.00019842808,0.00038007568,0.000020662314,0.00043237297,8.9177377e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01118189,0.0043917564,0.26688617,0.00046893736,0.0006005572,0.0000012215352,0.0036516024,0.0007991758,0.3074955,0.000009737581,0.000021279058,0.4044922],"study_design_scores_gemma":[0.05035649,0.0092645,0.7629318,0.00023367273,0.0023270585,0.0002802326,0.0028498755,0.047277264,0.114673115,0.0008872439,0.007941646,0.0009770935],"about_ca_topic_score_codex":0.0001183385,"about_ca_topic_score_gemma":0.0000035505855,"teacher_disagreement_score":0.49604565,"about_ca_system_score_codex":0.0001336535,"about_ca_system_score_gemma":0.00017881958,"threshold_uncertainty_score":0.5874284},"labels":[],"label_agreement":null},{"id":"W1980350591","doi":"10.1016/j.amjopharm.2008.05.001","title":"Adverse effects of propafenone after long-term therapy with the addition of citalopram","year":2008,"lang":"en","type":"article","venue":"The American journal of geriatric pharmacotherapy","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Propafenone; Citalopram; Medicine; Adverse effect; Anesthesia; Amlodipine; Acute coronary syndrome; Drug interaction; Atrial fibrillation; Internal medicine; Cardiology; Myocardial infarction; Serotonin; Pharmacokinetics","score_opus":0.005641649000057428,"score_gpt":0.250189551656002,"score_spread":0.24454790265594456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980350591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939842,0.0043912455,0.0004088193,0.00047230074,0.00015614009,0.0005251954,0.000006906817,0.000009909995,0.000045262557],"genre_scores_gemma":[0.9902057,0.007826976,0.00014426584,0.00096545304,0.00072073966,0.000025852682,0.000002026631,0.00003363097,0.00007534241],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984805,0.00030068634,0.00043153085,0.00013977097,0.0004057077,0.0002417783],"domain_scores_gemma":[0.99797267,0.0002719575,0.0011233911,0.00026251157,0.00027686445,0.00009259183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025732073,0.00021042628,0.00069589977,0.0001674946,0.0000902389,0.0000028452075,0.00017861646,0.000034173354,0.00011503918],"category_scores_gemma":[0.00000636925,0.00010081248,0.0003874802,0.00065907167,0.00078588,0.000089815134,0.000010761723,0.00039415338,0.0000027067658],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05859355,0.001156114,0.02010717,0.00014819574,0.0032420326,0.0021297806,0.0024523148,0.00009933985,0.8101592,0.000005577969,0.0020461928,0.099860534],"study_design_scores_gemma":[0.01864528,0.023398068,0.73225474,0.00026984364,0.0010442383,0.011587942,0.00022682617,0.000024888206,0.21052054,0.000035870915,0.0015513244,0.00044042637],"about_ca_topic_score_codex":0.000009363011,"about_ca_topic_score_gemma":6.4922534e-7,"teacher_disagreement_score":0.7121476,"about_ca_system_score_codex":0.000049805716,"about_ca_system_score_gemma":0.00025713822,"threshold_uncertainty_score":0.41110137},"labels":[],"label_agreement":null},{"id":"W1982873233","doi":"10.1016/j.amjopharm.2011.07.005","title":"Medication Reconciliation: Identifying Medication Discrepancies in Acutely Ill Hospitalized Older Adults","year":2011,"lang":"en","type":"article","venue":"The American journal of geriatric pharmacotherapy","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Medical prescription; Polypharmacy; Emergency medicine; Internal medicine","score_opus":0.06744962148721828,"score_gpt":0.37911600483081376,"score_spread":0.3116663833435955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982873233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98687124,0.0022550724,0.0025444853,0.0059842244,0.0010686305,0.0005724391,0.0000046437676,0.000030246489,0.0006690274],"genre_scores_gemma":[0.987212,0.0066819238,0.0015479041,0.0038942103,0.000513348,0.000023929917,0.0000055734577,0.00003089243,0.000090204005],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99737585,0.00034094055,0.0010306869,0.00022391632,0.0007240882,0.0003045115],"domain_scores_gemma":[0.99709874,0.0002834822,0.0017914337,0.00024233936,0.00031900487,0.00026498974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014143041,0.00021158143,0.00054420315,0.00033339308,0.00008878937,0.000023549339,0.00033432106,0.0000474016,0.00070930115],"category_scores_gemma":[0.00011313239,0.00013889933,0.00022599763,0.00078912685,0.00020801603,0.00048590422,0.00002290191,0.00051000825,0.000019842504],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018650701,0.0020523781,0.277548,0.00023182243,0.0013491082,0.0002853283,0.030829912,0.0000064473456,0.011780908,0.00010433706,0.0035262275,0.65363485],"study_design_scores_gemma":[0.02326596,0.0023283577,0.9123873,0.0004911886,0.0011537082,0.00097573077,0.0043425406,0.00255006,0.0050070416,0.0005080186,0.046320595,0.00066948566],"about_ca_topic_score_codex":0.00021695861,"about_ca_topic_score_gemma":0.000007440434,"teacher_disagreement_score":0.65296537,"about_ca_system_score_codex":0.00016095185,"about_ca_system_score_gemma":0.0002162062,"threshold_uncertainty_score":0.77663505},"labels":[],"label_agreement":null},{"id":"W1985401614","doi":"10.1016/j.amjopharm.2007.06.005","title":"Sex differences in inappropriate prescribing among elderly veterans","year":2007,"lang":"en","type":"article","venue":"The American journal of geriatric pharmacotherapy","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Family medicine; MEDLINE; Gerontology","score_opus":0.05985432686631161,"score_gpt":0.36687712028642544,"score_spread":0.30702279342011385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985401614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99409246,0.0010382526,0.0024866236,0.00087752636,0.00051976845,0.00037710986,0.0000021034377,0.00001986515,0.00058625796],"genre_scores_gemma":[0.99544895,0.0014455788,0.0005046853,0.001757567,0.00064699765,0.000003856034,5.803381e-7,0.000032537107,0.00015922337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974914,0.00031855307,0.000915064,0.00019619304,0.0005872411,0.00049154577],"domain_scores_gemma":[0.9976755,0.0007056823,0.0010180085,0.00018243077,0.000111568625,0.000306804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019638084,0.00024146131,0.00070043845,0.0003881964,0.00008957614,0.000047929865,0.0003335853,0.00004131619,0.00014222445],"category_scores_gemma":[0.000033000528,0.00014960092,0.00025269712,0.00085857767,0.00022962847,0.00027852863,0.000022781016,0.000884536,0.000005552773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005695455,0.0005020237,0.62328446,0.000037114558,0.000374495,0.00033898253,0.0027987463,0.000018946352,0.03351201,0.0000057292555,0.00017769868,0.33325437],"study_design_scores_gemma":[0.017577052,0.0070251967,0.93549293,0.00022359256,0.00072640553,0.0009983282,0.0036933338,0.0028394347,0.009572655,0.00024064418,0.02085692,0.00075348775],"about_ca_topic_score_codex":0.00016302138,"about_ca_topic_score_gemma":0.000011966727,"teacher_disagreement_score":0.33250087,"about_ca_system_score_codex":0.00010407399,"about_ca_system_score_gemma":0.00011509281,"threshold_uncertainty_score":0.61005485},"labels":[],"label_agreement":null},{"id":"W1987485899","doi":"10.1016/j.amjopharm.2011.02.007","title":"Elderly People's Knowledge of the Purpose of Their Medicines","year":2011,"lang":"en","type":"article","venue":"The American journal of geriatric pharmacotherapy","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"Réseau québécois de recherche sur le vieillissement","keywords":"Medicine; Medical prescription; Pharmacy; Odds ratio; Family medicine; Logistic regression; Drug; Confidence interval; Odds; Multivariate analysis; Psychiatry; Internal medicine; Nursing","score_opus":0.06286885919085687,"score_gpt":0.3659995720724815,"score_spread":0.30313071288162463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987485899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896265,0.005532225,0.00024451234,0.0016033747,0.0009476601,0.00042680162,0.000009235145,0.000009695582,0.0015999614],"genre_scores_gemma":[0.99387133,0.003982796,0.00024901616,0.001283307,0.00045390605,0.0000042929387,3.2354217e-7,0.000031823594,0.00012319743],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977823,0.00043546647,0.00096103933,0.0001330532,0.00042388114,0.00026429218],"domain_scores_gemma":[0.9962709,0.0006088304,0.0021647227,0.00034518907,0.00041006977,0.00020029068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009819525,0.00022591815,0.0008460022,0.00019732708,0.00007250386,0.0000057161355,0.000605572,0.0000345811,0.0004691285],"category_scores_gemma":[0.00004959543,0.000103403705,0.00051608536,0.0010653846,0.00046431366,0.00012875344,0.000046279743,0.00051098224,0.0000038086223],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011841307,0.00266119,0.19808136,0.00030638065,0.0021744366,0.000022970497,0.02490726,0.000008282477,0.21107094,0.00007291451,0.004063735,0.54478925],"study_design_scores_gemma":[0.03058127,0.022102533,0.44806987,0.0007476612,0.0058436845,0.0026414627,0.011423154,0.0011646259,0.23087135,0.0015245223,0.24395102,0.001078843],"about_ca_topic_score_codex":0.000075565986,"about_ca_topic_score_gemma":0.0000062424106,"teacher_disagreement_score":0.5437104,"about_ca_system_score_codex":0.00003517901,"about_ca_system_score_gemma":0.00029464916,"threshold_uncertainty_score":0.5136628},"labels":[],"label_agreement":null},{"id":"W1998605542","doi":"10.1016/j.amjopharm.2011.02.003","title":"Potentially Procholinergic Effects of Medications Commonly Used in Older Adults","year":2011,"lang":"en","type":"article","venue":"The American journal of geriatric pharmacotherapy","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Saint Vincent University; Carleton University; Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Butyrylcholinesterase; Cholinesterase; Pharmacology; Acetylcholinesterase; Medicine; Galantamine; Drug; Risperidone; Anticholinergic; Donepezil; Dementia; Disease; Internal medicine; Aché; Chemistry; Psychiatry; Enzyme; Biochemistry; Schizophrenia (object-oriented programming)","score_opus":0.013426322465004603,"score_gpt":0.2981972947770203,"score_spread":0.2847709723120157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998605542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99613976,0.0019636785,0.0007212611,0.00039283163,0.0002412119,0.00047323894,0.0000060757147,0.00001153691,0.000050399653],"genre_scores_gemma":[0.9957771,0.0017082028,0.00044983972,0.0015780478,0.00039893086,0.000019155475,0.0000027224378,0.000032668086,0.00003333784],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982596,0.0002648433,0.0007100743,0.00016085441,0.00039313477,0.00021147168],"domain_scores_gemma":[0.99817705,0.00018345444,0.00091993535,0.00022990479,0.00028179458,0.00020783812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026302252,0.00018774763,0.00058025646,0.00036867431,0.00004162699,0.0000071531877,0.00027430966,0.000025166664,0.00010363424],"category_scores_gemma":[0.000023629029,0.00012191338,0.0002520884,0.00083551405,0.00019261189,0.00010022024,0.000015526643,0.00029021743,0.0000027436106],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016643366,0.008185021,0.13970174,0.0004438509,0.0012269763,0.0009854252,0.015389461,0.00004316353,0.68066055,0.000019191417,0.002304537,0.13439673],"study_design_scores_gemma":[0.026332986,0.0034347954,0.78077835,0.0006029423,0.0010680596,0.00073105824,0.000711,0.00025873023,0.18487744,0.000058874153,0.00074041385,0.00040535364],"about_ca_topic_score_codex":0.00006655144,"about_ca_topic_score_gemma":0.0000068143668,"teacher_disagreement_score":0.6410766,"about_ca_system_score_codex":0.000031355336,"about_ca_system_score_gemma":0.00028390184,"threshold_uncertainty_score":0.4971483},"labels":[],"label_agreement":null},{"id":"W2002702566","doi":"10.1016/j.amjopharm.2011.09.006","title":"Detection and Prevention of Drug–Drug Interactions in the Hospitalized Elderly: Utility of New Cytochrome P450–Based Software","year":2011,"lang":"en","type":"article","venue":"The American journal of geriatric pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire de Gériatrie de Montréal; Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Polypharmacy; Medicine; Drug; CYP2D6; Prospective cohort study; Internal medicine; Drug interaction; Pharmacology; Cytochrome P450","score_opus":0.0715310687299459,"score_gpt":0.3993760881135736,"score_spread":0.3278450193836277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002702566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902923,0.003069589,0.0048858216,0.00040143862,0.00068104296,0.00051450904,0.000028439272,0.000013061469,0.00011380989],"genre_scores_gemma":[0.9952388,0.0024069885,0.0011026503,0.00085691904,0.00029379086,0.00001931816,0.0000013412925,0.000026595748,0.000053607673],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99652255,0.0015961326,0.001043781,0.00020907419,0.0003239071,0.00030457057],"domain_scores_gemma":[0.99702805,0.0005140092,0.0018280462,0.00022470775,0.00022764306,0.00017752235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021997797,0.0002599167,0.0006098139,0.00037957326,0.00013748025,0.000013734081,0.00058239774,0.000040006118,0.0005594646],"category_scores_gemma":[0.000029991656,0.00017787749,0.00032508714,0.0008871071,0.00040614422,0.00017211544,0.000033825643,0.0007966251,0.0000016842793],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068489173,0.0013993271,0.014657618,0.00007482136,0.0006966924,0.000021231797,0.012644864,0.00018359553,0.36832374,0.000008838814,0.0017531232,0.5933872],"study_design_scores_gemma":[0.025448676,0.0022420129,0.37212858,0.00011809626,0.002724742,0.00037912393,0.0038246375,0.004801839,0.5218065,0.006162834,0.05939153,0.0009714697],"about_ca_topic_score_codex":0.000325235,"about_ca_topic_score_gemma":0.00004713586,"teacher_disagreement_score":0.59241575,"about_ca_system_score_codex":0.00003295667,"about_ca_system_score_gemma":0.00023463825,"threshold_uncertainty_score":0.7253633},"labels":[],"label_agreement":null},{"id":"W2024123016","doi":"10.1016/s1543-5946(04)90004-9","title":"Comparison of anti-infective drug use in elderly persons in Manitoba, Nova Scotia, and Saskatchewan, Canada: Relationship to drug insurance reimbursement policies","year":2004,"lang":"en","type":"article","venue":"The American journal of geriatric pharmacotherapy","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Health; University of Saskatchewan; Manitoba Health; University of Manitoba; Dalhousie University","funders":"","keywords":"Reimbursement; Nova scotia; Medicine; Medical prescription; Family medicine; Antimicrobial; Environmental health; Geography; Health care; Pharmacology; Economic growth","score_opus":0.017484611881220056,"score_gpt":0.2874923805243199,"score_spread":0.27000776864309983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024123016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935609,0.0044746217,0.00016186752,0.0011383155,0.00036061107,0.00025744992,0.00002580759,0.000004734528,0.000015704369],"genre_scores_gemma":[0.9989103,0.0003251276,0.00016680299,0.0004508621,0.000046308014,0.0000012443987,0.0000011824437,0.000016212427,0.00008196461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984343,0.0003230679,0.0006586787,0.00017198182,0.00010432926,0.00030764367],"domain_scores_gemma":[0.9987289,0.00029925752,0.00069186895,0.00013824104,0.00009251605,0.000049249127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040814164,0.00018469014,0.00059211365,0.00032924878,0.000086893226,0.000014491681,0.00023900166,0.000037226422,0.000013137111],"category_scores_gemma":[0.000016210699,0.00014142867,0.000072540395,0.0007520412,0.00026246734,0.00011115291,0.000021229433,0.0005008925,0.0000024342896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055900007,0.00028382032,0.91471773,0.000015550577,0.00015731956,0.000019300098,0.012318818,0.0010614465,0.066588454,0.000015128934,0.0011848129,0.0030786002],"study_design_scores_gemma":[0.0027684134,0.00029276274,0.95742124,0.00012620982,0.000038153026,0.00004254313,0.01993318,0.000001716143,0.01850101,0.00003029926,0.0006607758,0.00018371953],"about_ca_topic_score_codex":0.49667257,"about_ca_topic_score_gemma":0.7767915,"teacher_disagreement_score":0.2801189,"about_ca_system_score_codex":0.00025547546,"about_ca_system_score_gemma":0.0005765417,"threshold_uncertainty_score":0.57672936},"labels":[],"label_agreement":null},{"id":"W2032878259","doi":"10.1016/j.amjopharm.2006.03.001","title":"Azathioprine and inhibition of the anticoagulant effect of warfarin: Evidence from a case report and a literature review","year":2006,"lang":"en","type":"review","venue":"The American journal of geriatric pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McMaster University","funders":"China Aerospace Science and Technology Corporation; Heart and Stroke Foundation of Canada","keywords":"Warfarin; Azathioprine; Discontinuation; Medicine; Drug interaction; Anticoagulant; Gastroenterology; Internal medicine; Pharmacology; Pharmacokinetics; Atrial fibrillation","score_opus":0.06018615349957545,"score_gpt":0.43892958919414293,"score_spread":0.3787434356945675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032878259","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13447827,0.8630171,0.000029650459,0.00019929466,0.0008413614,0.001183906,0.00022693315,0.000008049868,0.000015475669],"genre_scores_gemma":[0.016924646,0.9814737,0.000107226195,0.00054351246,0.0007994765,0.00003533052,0.000009764236,0.000063901796,0.00004243474],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926701,0.0038176859,0.0022556894,0.0004262008,0.00047089282,0.00035939654],"domain_scores_gemma":[0.990658,0.0019398164,0.006372451,0.000462303,0.00032677114,0.00024066253],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0038022178,0.00067510235,0.0033215901,0.00029520673,0.00018173405,0.000034503504,0.00055620295,0.0002140398,0.00006241601],"category_scores_gemma":[0.00010246903,0.00035773544,0.00089406024,0.0013044194,0.00072143937,0.00012168395,0.00018805372,0.0017326412,8.552561e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053945975,0.00017717747,0.00029176346,0.0145243285,0.0014541863,0.008419688,0.0003291641,0.000008166829,0.008709626,0.0000026875,0.0015181504,0.9640256],"study_design_scores_gemma":[0.0035418707,0.00090500095,0.00012578834,0.033848945,0.020835772,0.13971975,0.000018804416,0.00009466438,0.006194034,0.0000681895,0.7938648,0.00078239717],"about_ca_topic_score_codex":0.00009237422,"about_ca_topic_score_gemma":0.0000024876126,"teacher_disagreement_score":0.9632432,"about_ca_system_score_codex":0.000049350183,"about_ca_system_score_gemma":0.00033855962,"threshold_uncertainty_score":0.99988747},"labels":[],"label_agreement":null},{"id":"W2041413763","doi":"10.1016/j.amjopharm.2012.11.001","title":"Atypical Antipsychotic Use and Parkinsonism in Dementia: Effects of Drug, Dose, and Sex","year":2012,"lang":"en","type":"article","venue":"The American journal of geriatric pharmacotherapy","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital; University of Toronto; Toronto Western Hospital","funders":"Institute of Gender and Health; Canadian Institutes of Health Research; H. Lundbeck A/S","keywords":"Olanzapine; Parkinsonism; Risperidone; Quetiapine; Medicine; Antipsychotic; Dementia; Hazard ratio; Extrapyramidal symptoms; Internal medicine; Psychiatry; Pediatrics; Schizophrenia (object-oriented programming); Confidence interval","score_opus":0.01243382426237553,"score_gpt":0.2913810641021688,"score_spread":0.27894723983979325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041413763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833385,0.015685417,0.00023397697,0.0001734955,0.00024113712,0.0003055591,0.000003888852,0.0000066026623,0.000011475479],"genre_scores_gemma":[0.98769885,0.0104365945,0.0009900834,0.0005925258,0.0002237901,0.000007382242,5.8060544e-7,0.000026860687,0.000023328847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861455,0.00024023083,0.00040718913,0.00014781204,0.00027873355,0.00031150042],"domain_scores_gemma":[0.9987435,0.0002534099,0.0004936531,0.00013545483,0.000046404086,0.00032757988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041744258,0.00019620717,0.00056279846,0.0002412215,0.000051376144,0.000021092575,0.000086523265,0.000026923713,0.000023190198],"category_scores_gemma":[0.000010655564,0.00012922066,0.00011244201,0.00034507472,0.0001564347,0.00018123293,0.000019325107,0.0002077135,0.0000011442343],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039398847,0.0014886027,0.7961391,0.00011172548,0.0012411323,0.00017918483,0.0013096869,0.0000017388527,0.048267834,0.000018111947,0.0003879487,0.14691505],"study_design_scores_gemma":[0.010086041,0.0008901634,0.97445303,0.00008277175,0.00075869577,0.00043555623,0.0001288549,0.00006696924,0.0051880786,0.00009193574,0.0076673673,0.00015054195],"about_ca_topic_score_codex":0.000032340453,"about_ca_topic_score_gemma":0.0000010716595,"teacher_disagreement_score":0.17831391,"about_ca_system_score_codex":0.00003656736,"about_ca_system_score_gemma":0.000058226888,"threshold_uncertainty_score":0.52694654},"labels":[],"label_agreement":null},{"id":"W2059357945","doi":"10.1016/j.amjopharm.2011.03.002","title":"Balance Control Improves Following Replacement of Paroxetine with Venlafaxine and Levodopa in a Case of Microvascular Dementia","year":2011,"lang":"en","type":"article","venue":"The American journal of geriatric pharmacotherapy","topic":"Balance, Gait, and Falls Prevention","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval; Ste. Anne's Hospital","funders":"Natural Sciences and Engineering Research Council of Canada; Teva Pharmaceutical Industries","keywords":"Venlafaxine; Paroxetine; Medicine; Posturography; Levodopa; Anesthesia; Serotonergic; Reuptake inhibitor; Dopaminergic; Internal medicine; Parkinson's disease; Serotonin; Physical medicine and rehabilitation; Balance (ability); Dopamine; Antidepressant; Hippocampus; Disease","score_opus":0.013870416965158824,"score_gpt":0.31864792812499587,"score_spread":0.30477751115983703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059357945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921712,0.0042153113,0.0026641088,0.0001126504,0.00022466226,0.00053574954,0.0000088261295,0.0000060055836,0.00006146971],"genre_scores_gemma":[0.9958449,0.0017107186,0.0019131294,0.0003268704,0.0001307125,0.000022697497,6.95438e-7,0.00002496229,0.00002530461],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975999,0.00069380994,0.0010232024,0.00016489379,0.00021446568,0.00030370135],"domain_scores_gemma":[0.99724215,0.0001769145,0.0021246453,0.00020649574,0.00015469354,0.00009511039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019375791,0.00017224225,0.0006876725,0.00018759869,0.00010604903,0.0000034085003,0.00018745747,0.00003323793,0.000027722484],"category_scores_gemma":[0.000011082596,0.000113514456,0.00016690964,0.00041662474,0.00013485113,0.00011072954,0.0000215401,0.00035284454,6.442814e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008600423,0.000990914,0.27683136,0.0002515738,0.0017825705,0.0003177564,0.0059998236,0.0000041911944,0.67787707,0.000013691271,0.0002891845,0.02704148],"study_design_scores_gemma":[0.10486162,0.0126390895,0.8457961,0.0014980917,0.0031466049,0.0018357409,0.015351888,0.0014856961,0.0069974842,0.0004929295,0.004771717,0.0011230425],"about_ca_topic_score_codex":0.0005627405,"about_ca_topic_score_gemma":0.000043832417,"teacher_disagreement_score":0.67087954,"about_ca_system_score_codex":0.000042212774,"about_ca_system_score_gemma":0.00016095932,"threshold_uncertainty_score":0.46289852},"labels":[],"label_agreement":null},{"id":"W2063827270","doi":"10.1016/j.amjopharm.2007.03.007","title":"Self-reported understanding of diabetes and its treatment among elderly ambulatory subjects in British Columbia","year":2007,"lang":"en","type":"article","venue":"The American journal of geriatric pharmacotherapy","topic":"Diabetes Management and Education","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Medical prescription; Recall; Ambulatory; Disease; Diabetes mellitus; Outpatient clinic; Internal medicine; Psychology","score_opus":0.01832680628377019,"score_gpt":0.28256848758935216,"score_spread":0.26424168130558195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063827270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969204,0.0020769804,0.00006307178,0.00011513278,0.00026268594,0.00036799448,0.0000012923286,0.000016096008,0.00017632342],"genre_scores_gemma":[0.9972041,0.0020064488,0.00016321235,0.00017550109,0.00024310242,0.000004196452,0.0000013103215,0.000025473828,0.00017662029],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985975,0.00008042798,0.0006129778,0.0001416694,0.00027259428,0.00029483286],"domain_scores_gemma":[0.9986013,0.00012691694,0.0009246922,0.000101221594,0.00009474531,0.0001510778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094637903,0.000116130104,0.00046395828,0.0002670964,0.00006385342,0.000059854596,0.00008933524,0.000025978869,0.0000583886],"category_scores_gemma":[0.000009865399,0.00012148326,0.00011149427,0.0007140922,0.00010591423,0.00014286545,0.000008490529,0.00014128734,4.4158068e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016223406,0.00056480424,0.90757203,0.00006663331,0.000895396,0.00007699839,0.0011751144,0.0000047234016,0.013551465,0.0000017501371,0.00053106854,0.075397775],"study_design_scores_gemma":[0.0053025684,0.0026658336,0.98559403,0.00012687656,0.00064917235,0.0000611891,0.002318106,0.00021282643,0.0018167351,0.00010852337,0.00095205393,0.0001920682],"about_ca_topic_score_codex":0.00046609004,"about_ca_topic_score_gemma":0.0005995549,"teacher_disagreement_score":0.07802201,"about_ca_system_score_codex":0.00033438255,"about_ca_system_score_gemma":0.0001291441,"threshold_uncertainty_score":0.49539435},"labels":[],"label_agreement":null},{"id":"W2068236212","doi":"10.1016/j.amjopharm.2004.09.001","title":"Use of gastrointestinal preventive therapy among elderly persons receiving antiarthritic agents in Nova Scotia, Canada","year":2004,"lang":"en","type":"article","venue":"The American journal of geriatric pharmacotherapy","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Capital District Health Authority; Fraser Health; Dalhousie University","funders":"","keywords":"Medicine; Rofecoxib; Medical prescription; Aspirin; Celecoxib; Internal medicine; Logistic regression; Proportional hazards model; Retrospective cohort study; Risk factor; Nova scotia; Cyclooxygenase; Pharmacology","score_opus":0.0212139112557899,"score_gpt":0.28822636138786983,"score_spread":0.2670124501320799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068236212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974648,0.00070778717,0.00047972525,0.00039136538,0.00044815452,0.00046837408,0.000009874902,0.000008989719,0.00002092756],"genre_scores_gemma":[0.9973864,0.0005089259,0.0009921016,0.00062023464,0.00040662804,0.0000034976986,0.0000012755171,0.000047382207,0.000033584107],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975884,0.00031691656,0.0008038471,0.00019942055,0.0006333756,0.0004580392],"domain_scores_gemma":[0.9978601,0.00028280367,0.0011461204,0.00021101059,0.00023978941,0.00026017363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070786785,0.00027632626,0.00074808265,0.00034618672,0.00006262737,0.00002437286,0.0002454998,0.000026336396,0.00013591698],"category_scores_gemma":[0.000053376552,0.000200909,0.00025266426,0.0008459161,0.00026615473,0.00021139556,0.00001370216,0.00057072955,0.0000017043478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047475095,0.0008654651,0.7697276,0.00009704205,0.00059071556,0.0019730953,0.0024355114,0.0014772387,0.14561076,0.0000031826612,0.0022054892,0.07026637],"study_design_scores_gemma":[0.014867797,0.0058868616,0.9496456,0.0013148569,0.00021381839,0.002547928,0.00095746206,0.00026067437,0.022915686,0.000028288478,0.0008866291,0.00047442602],"about_ca_topic_score_codex":0.096039265,"about_ca_topic_score_gemma":0.030508086,"teacher_disagreement_score":0.17991796,"about_ca_system_score_codex":0.00032723654,"about_ca_system_score_gemma":0.0015374362,"threshold_uncertainty_score":0.9871826},"labels":[],"label_agreement":null},{"id":"W2076518735","doi":"10.1016/j.amjopharm.2006.06.004","title":"Thiazide diuretics for hypertension: Prescribing practices and predictors of use in 194,761 elderly patients with hypertension","year":2006,"lang":"en","type":"article","venue":"The American journal of geriatric pharmacotherapy","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Institute for Clinical Evaluative Sciences; University of Calgary; University of Toronto; University Health Network; Toronto Western Hospital","funders":"Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; University of Alberta; Heart and Stroke Foundation of Canada; Merck","keywords":"Thiazide; Medicine; Diuretic; Internal medicine; Medical prescription; Odds ratio; Hydrochlorothiazide; Cohort; Population; Diabetes mellitus; Pediatrics; Endocrinology; Blood pressure; Pharmacology; Environmental health","score_opus":0.026194648090413476,"score_gpt":0.2734139537586482,"score_spread":0.24721930566823472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076518735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99126995,0.0065974914,0.00013148821,0.001160579,0.0002274823,0.0005653922,0.000013921337,0.000012507698,0.000021202732],"genre_scores_gemma":[0.9932278,0.0021276593,0.0024432994,0.0016544025,0.00044854,0.000008647365,0.0000029070313,0.00004195604,0.00004479982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815935,0.00014870761,0.00070266245,0.00022015968,0.00049954903,0.00026959353],"domain_scores_gemma":[0.9963405,0.0007920225,0.0017572587,0.00019470103,0.0008100787,0.00010544866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044208296,0.00023592339,0.0009400658,0.00026765198,0.00010974139,0.000030373425,0.00012619827,0.000045236357,0.0000057121897],"category_scores_gemma":[0.00007339105,0.00013281238,0.0001325659,0.00042704007,0.0002530142,0.0002516404,0.000026264168,0.00029952227,2.1368152e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017929077,0.0018166179,0.8668261,0.00014829448,0.0016386905,0.00016948459,0.0007704613,0.00010091859,0.063122846,0.00000780468,0.01863092,0.02883875],"study_design_scores_gemma":[0.028770024,0.010894824,0.8958985,0.00047129235,0.0051391656,0.0010496317,0.00097314955,0.000592472,0.004258988,0.00008309742,0.051337253,0.0005315535],"about_ca_topic_score_codex":0.00023657164,"about_ca_topic_score_gemma":0.000022374088,"teacher_disagreement_score":0.058863856,"about_ca_system_score_codex":0.000015687296,"about_ca_system_score_gemma":0.00011041315,"threshold_uncertainty_score":0.5415932},"labels":[],"label_agreement":null},{"id":"W2079738466","doi":"10.1016/j.amjopharm.2009.12.003","title":"Self-reported use of natural health products: A cross-sectional telephone survey in older Ontarians","year":2009,"lang":"en","type":"article","venue":"The American journal of geriatric pharmacotherapy","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Cross-sectional study; Medicine; Telephone survey; Traditional medicine; Environmental health; Family medicine; Business; Advertising","score_opus":0.05752925540779846,"score_gpt":0.38681588784468146,"score_spread":0.329286632436883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079738466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99358946,0.0021458487,0.00022332721,0.0028077336,0.0007002438,0.00049103773,0.000017627011,0.000015838074,0.000008888264],"genre_scores_gemma":[0.9934016,0.002039839,0.001272507,0.0022501233,0.00089834904,0.0000033066517,0.000009439185,0.000017547252,0.0001073129],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99719024,0.00039466567,0.0012533317,0.0002294573,0.00059880165,0.00033351668],"domain_scores_gemma":[0.99719113,0.00029553642,0.0016559075,0.00019264332,0.0005348205,0.00012996442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016089685,0.00022455036,0.0008194567,0.00039057437,0.00009916112,0.000019232086,0.00018890115,0.0000074665845,0.000092340575],"category_scores_gemma":[0.000071772076,0.00014526721,0.00016679397,0.0012383545,0.0001848531,0.00016410553,0.00001613297,0.00052984786,7.370179e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036658717,0.00096631487,0.96008,0.000027657063,0.0008422302,0.00009539699,0.0013774637,0.000030884563,0.0090668695,0.0000015081291,0.0017008127,0.022144975],"study_design_scores_gemma":[0.0054700575,0.0025399714,0.986484,0.000041831252,0.000066266235,0.0006286262,0.00010276338,0.000049208295,0.0006744042,0.000012286503,0.003810442,0.000120152785],"about_ca_topic_score_codex":0.0019459749,"about_ca_topic_score_gemma":0.00019175248,"teacher_disagreement_score":0.026403975,"about_ca_system_score_codex":0.000247686,"about_ca_system_score_gemma":0.00052840955,"threshold_uncertainty_score":0.5923825},"labels":[],"label_agreement":null},{"id":"W2090113900","doi":"10.1016/j.amjopharm.2011.07.003","title":"Cytochrome P450 2D6 Phenotyping in an Elderly Population With Dementia and Response to Galantamine in Dementia: A Pilot Study","year":2011,"lang":"en","type":"article","venue":"The American journal of geriatric pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University; Health Sciences North","funders":"","keywords":"Galantamine; Medicine; CYP2D6; Dextromethorphan; Dementia; Population; Dextrorphan; Internal medicine; Pharmacology; Disease; Donepezil; Cytochrome P450","score_opus":0.07233219960403652,"score_gpt":0.39006184127772103,"score_spread":0.3177296416736845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090113900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961479,0.0019921921,0.00040358194,0.00016642269,0.0002949901,0.0009271519,0.000011108107,0.000018393444,0.000038264046],"genre_scores_gemma":[0.9965025,0.00080906437,0.00078519265,0.0015112231,0.00026997217,0.000054513857,0.0000014712184,0.000055017725,0.000011047899],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99538344,0.0024088668,0.0009387577,0.0003664293,0.00033904062,0.00056344864],"domain_scores_gemma":[0.9982781,0.00023204308,0.000757922,0.00020902121,0.00013504765,0.00038787522],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0034361535,0.00035334012,0.0006448716,0.0008559205,0.00017010407,0.00004179456,0.00052000885,0.000042789427,0.00025286627],"category_scores_gemma":[0.000010334649,0.0002685941,0.000056124692,0.001220501,0.00013490961,0.00026778784,0.000061317995,0.0007537349,0.000004714049],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05248542,0.0033123344,0.34587684,0.00001182648,0.00077126286,0.00029337103,0.010757251,0.0007508084,0.49855617,0.000006388277,0.000037603917,0.08714073],"study_design_scores_gemma":[0.013728375,0.012143178,0.9660291,0.000021649717,0.0006675786,0.00015510274,0.0014102956,0.00074973836,0.003014725,0.000096276206,0.001513866,0.00047007875],"about_ca_topic_score_codex":0.00035465654,"about_ca_topic_score_gemma":0.0002843245,"teacher_disagreement_score":0.6201523,"about_ca_system_score_codex":0.00009259473,"about_ca_system_score_gemma":0.00014293894,"threshold_uncertainty_score":0.99997663},"labels":[],"label_agreement":null},{"id":"W2094241410","doi":"10.1016/j.amjopharm.2007.05.003","title":"Use of wet nebulized inhaled respiratory medications under criteria-based reimbursement guidelines in a publicly funded seniors' pharmacare program in Nova Scotia, Canada","year":2007,"lang":"en","type":"article","venue":"The American journal of geriatric pharmacotherapy","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Capital District Health Authority; Dalhousie University","funders":"","keywords":"Reimbursement; Medicine; Nova scotia; Authorization; Family medicine; Residence; Emergency medicine; Medical emergency; Demography; Health care","score_opus":0.05790437523715792,"score_gpt":0.39135388929584136,"score_spread":0.33344951405868345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094241410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99085194,0.0012241651,0.0010264113,0.005102151,0.00068686466,0.00096253474,0.000019416657,0.00002607097,0.000100471654],"genre_scores_gemma":[0.9814732,0.00016862481,0.0022980284,0.015371459,0.0005522467,0.000014720943,0.000007167895,0.00005154439,0.00006300026],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954399,0.0005318675,0.002194557,0.00028276458,0.0010470527,0.0005038774],"domain_scores_gemma":[0.9961256,0.0003744039,0.00164907,0.00034983936,0.0011426838,0.00035845255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024668064,0.00031182557,0.0008386405,0.0012133796,0.0000618483,0.00003660302,0.00035409254,0.00006970823,0.00052140764],"category_scores_gemma":[0.00009508702,0.00022989913,0.00022467351,0.0024991252,0.00027633438,0.0002001431,0.000024164789,0.00062986475,0.0000019133456],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021117823,0.0055817408,0.1768062,0.0003440663,0.0016581411,0.0025992366,0.0016323312,0.004781621,0.3240995,0.000022146089,0.076935984,0.3844212],"study_design_scores_gemma":[0.10618268,0.0076005156,0.1899219,0.0016662187,0.0017166024,0.0012181624,0.009527936,0.01590928,0.13646127,0.000037286423,0.52695256,0.0028055448],"about_ca_topic_score_codex":0.06725255,"about_ca_topic_score_gemma":0.096189596,"teacher_disagreement_score":0.4500166,"about_ca_system_score_codex":0.00059841503,"about_ca_system_score_gemma":0.0031243602,"threshold_uncertainty_score":0.9389587},"labels":[],"label_agreement":null},{"id":"W2137678049","doi":"10.1016/j.amjopharm.2012.11.002","title":"Use of Rivastigmine or Galantamine and Risk of Adverse Cardiac Events: A Database Study from the Netherlands","year":2012,"lang":"en","type":"article","venue":"The American journal of geriatric pharmacotherapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"Canadian Institutes of Health Research; Top Institute Pharma; Novo Nordisk; Ministerie van Volksgezondheid, Welzijn en Sport; Universiteit Utrecht; GlaxoSmithKline","keywords":"Medicine; Galantamine; Hazard ratio; Rivastigmine; Adverse effect; Incidence (geometry); Internal medicine; Cohort; Discontinuation; Proportional hazards model; Cohort study; Confidence interval; Tolerability; Cardiology; Donepezil; Dementia; Disease","score_opus":0.031307280719038356,"score_gpt":0.3445457636643336,"score_spread":0.3132384829452952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137678049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629676,0.002079407,0.00043240216,0.00015791196,0.00018521259,0.0006342582,0.00019731365,0.000004728825,0.000011981854],"genre_scores_gemma":[0.98723257,0.011431764,0.0003366579,0.00018811383,0.00065200037,0.0000111422105,0.000006119606,0.000026499847,0.00011511811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973198,0.0009161199,0.0006260361,0.00013534084,0.00070445467,0.00029823193],"domain_scores_gemma":[0.99707305,0.0010379833,0.0010972308,0.00029849866,0.00026919506,0.00022404897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017345857,0.0001915571,0.0006604511,0.00016426186,0.00007617302,0.000007481878,0.00022976828,0.000016551912,0.00033061914],"category_scores_gemma":[0.0000830247,0.000090499765,0.00020468605,0.0006124147,0.00025978312,0.00020950373,0.00006364324,0.00034393172,0.0000018133275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007849956,0.001266658,0.9233923,0.000014540169,0.0023174407,0.000018254434,0.0015724767,0.0000018190623,0.032664794,1.7974473e-7,0.0009969688,0.029904624],"study_design_scores_gemma":[0.005837974,0.003439091,0.9789552,0.00005577531,0.0019040231,0.00006119886,0.0029994794,0.000034646586,0.003344063,0.0000029275166,0.0032607345,0.00010490318],"about_ca_topic_score_codex":0.0006537846,"about_ca_topic_score_gemma":0.000006728101,"teacher_disagreement_score":0.055562895,"about_ca_system_score_codex":0.000028709139,"about_ca_system_score_gemma":0.00014128786,"threshold_uncertainty_score":0.3690473},"labels":[],"label_agreement":null},{"id":"W2339966898","doi":"10.1016/j.amjopharm.2011.01.002","title":"Letter to the Editor","year":2011,"lang":"en","type":"letter","venue":"The American journal of geriatric pharmacotherapy","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cancer research; Gene silencing; Alternative splicing; MAPK/ERK pathway; Cell growth; RNA splicing; Medicine; Cancer; Biology; Signal transduction; Gene; Exon; Cell biology; RNA; Internal medicine; Genetics","score_opus":0.012352931233003354,"score_gpt":0.2912887738351036,"score_spread":0.27893584260210025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339966898","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.086058706,0.00436715,0.0047692014,0.89322823,0.010276492,0.000846941,0.00007056681,0.000015275698,0.0003674622],"genre_scores_gemma":[0.006092178,0.0018758237,0.00025030618,0.78899485,0.19814046,0.000026660937,0.00001007711,0.00009969175,0.0045099813],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974048,0.0005524978,0.000519415,0.00029852032,0.0006226531,0.0006020709],"domain_scores_gemma":[0.9980547,0.00008583062,0.00084875117,0.0005741081,0.00026797893,0.00016863996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008906912,0.00034787538,0.00045535518,0.00018405303,0.00017405792,0.000086173146,0.0017263454,0.00016197076,0.00012825997],"category_scores_gemma":[0.000020698546,0.00018541557,0.0004690244,0.00036983087,0.00021712005,0.000006072429,0.00010417686,0.0016845742,0.000051556002],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042250415,0.00001946639,0.00002168845,0.0000063665416,0.0003316243,0.00006032228,0.000069434784,0.00000858884,0.11562982,9.184507e-8,0.86910015,0.014329957],"study_design_scores_gemma":[0.00046652535,0.0010160522,0.000043417087,0.000011251176,0.00006377874,0.00015429409,0.000019603895,0.00000466863,0.0053501315,0.0000076151255,0.99262214,0.00024052641],"about_ca_topic_score_codex":0.000063763364,"about_ca_topic_score_gemma":0.0000041013627,"teacher_disagreement_score":0.18786396,"about_ca_system_score_codex":0.0000423928,"about_ca_system_score_gemma":0.0002725638,"threshold_uncertainty_score":0.75610274},"labels":[],"label_agreement":null}]}